Lataa...
PCSK9 targets important for lipid metabolism
Ischemic heart disease is the main cause of death worldwide and it is accelerated by increased low-density lipoprotein (LDL) cholesterol (LDL-C) and/or lipoprotein (a) (Lp(a)) concentrations. Proprotein convertase subtilisin/kexin type 9 (PCSK9) alters both LDL-C and in part Lp(a) concentrations thr...
Tallennettuna:
| Julkaisussa: | Clin Res Cardiol Suppl |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Berlin Heidelberg
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5352789/ https://ncbi.nlm.nih.gov/pubmed/28176216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11789-017-0085-0 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|